VTRS Q1 2020 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.6B+5.0% YoY

Gross Profit

$906M34.6% margin

Operating Income

$185M7.1% margin

Net Income

$21M0.8% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-17.9%

Cash Flow

Operating Cash Flow

$291M

Free Cash Flow

$248M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$30.1B

Total Liabilities

$18.9B

Stockholders' Equity

$11.3B

Cash & Equivalents

$572M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.6B	$2.5B	+5.0%
Gross Profit	$906M	$805M	+12.5%
Operating Income	$185M	$24M	+669.6%
Net Income	$21M	-$25M	+183.2%